US biotech Alnylam hails positive trial results for heart disease drug
Vutrisiran injection cut risk of death and adverse cardiovascular events by at least 28%, company says
Info Econômico – Seu Portal de Notícias Econômicas
Fonte US biotech Alnylam hails positive trial results for heart disease drug